Table 1. Characteristics of Veterans identified with a positive COVID -19 diagnosis by lab test at VA, and CAN score, from March 2, 2020 to May 26, 2020.
| All Patients in Cohort | Patients with CAN ≤ 50 | Patients with CAN > 50 | |
|---|---|---|---|
| Characteristic | n = 6591 | n = 3376 | n = 3215 |
| CAN—Mortality 1 Year (Mean) (SD) | 52.1 (32.3) | 24.2 (15.7) | 81.4 (14.5) |
| Male (%) | 5996 (91%) | 2848 (84.4%) | 3148 (97.9%) |
| Age (Mean) (SD) | 61.9 (15.5) | 51.7 (12.7) | 72.6 (10) |
| Hypertension | 4679 (71%) | 1886 (55.9%) | 2793 (86.9%) |
| COPD | 2733 (41.5%) | 962 (28.5%) | 1771 (55.1%) |
| CHF | 1405 (21.3%) | 200 (5.9%) | 1205 (37.5%) |
| Diabetes | 2910 (44.2%) | 1011 (30%) | 1899 (59.1%) |
| Charlson Comorbidity Index (CCI) (SD) | 3.7 (3.7) | 1.66 (2.2) | 5.82 (3.8) |
| AMERICAN INDIAN, ALASKA NATIVE OR OTHER PACIFIC ISLANDER | 116 (1.8%) | 60 (1.8%) | 56 (1.7%) |
| ASIAN | 74 (1.1%) | 58 (1.7%) | 16 (0.5%) |
| BLACK OR AFRICAN AMERICAN | 3162 (47.8%) | 1689 (50%) | 1473 (45.8%) |
| WHITE | 2823 (42.8%) | 1312 (38.9%) | 1511 (47%) |
| DECLINED TO ANSWER | 268 (4.1%) | 173 (5.1%) | 95 (3%) |
| UNKNOWN BY PATIENT | 76 (1.2%) | 41 (1.2%) | 35 (1.1%) |
| NOT REPORTED | 72 (1.1%) | 43 (1.3%) | 29 (0.9%) |